MCID: STM003
MIFTS: 18

Stomach Carcinoma in Situ malady

Categories: Cancer diseases, Gastrointestinal diseases, Rare diseases, Genetic diseases

Aliases & Classifications for Stomach Carcinoma in Situ

Aliases & Descriptions for Stomach Carcinoma in Situ:

Name: Stomach Carcinoma in Situ 12 14
Carcinoma in Situ of Stomach 12 69
Gastric Carcinoma in Situ 12

Classifications:



External Ids:

Disease Ontology 12 DOID:9138
ICD10 33 D00.2
ICD9CM 35 230.2
NCIt 47 C7788
SNOMED-CT 64 189223002 92756002
UMLS 69 C0154060

Summaries for Stomach Carcinoma in Situ

MalaCards based summary : Stomach Carcinoma in Situ, also known as carcinoma in situ of stomach, is related to esophagus carcinoma in situ and lip carcinoma in situ. An important gene associated with Stomach Carcinoma in Situ is CRLF1 (Cytokine Receptor Like Factor 1). The drugs Fentanyl and pancreatic polypeptide have been mentioned in the context of this disorder.

Related Diseases for Stomach Carcinoma in Situ

Diseases in the Familial Stomach Cancer family:

Stomach Carcinoma in Situ

Diseases related to Stomach Carcinoma in Situ via text searches within MalaCards or GeneCards Suite gene sharing:

id Related Disease Score Top Affiliating Genes
1 esophagus carcinoma in situ 10.4
2 lip carcinoma in situ 10.2
3 liver leiomyoma 9.8 CRLF1 GLS2

Comorbidity relations with Stomach Carcinoma in Situ via Phenotypic Disease Network (PDN):


Gastric Cancer, Somatic

Symptoms & Phenotypes for Stomach Carcinoma in Situ

Drugs & Therapeutics for Stomach Carcinoma in Situ

Drugs for Stomach Carcinoma in Situ (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 43)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
2 pancreatic polypeptide Phase 3
3 Analgesics Phase 3
4 Adjuvants, Anesthesia Phase 3
5 Narcotics Phase 3
6 Analgesics, Opioid Phase 3
7 Anesthetics Phase 3
8 Anesthetics, General Phase 3
9 Anesthetics, Intravenous Phase 3
10 Peripheral Nervous System Agents Phase 3
11 Liver Extracts Phase 3
12 Central Nervous System Depressants Phase 3
13 Cola Nutraceutical Phase 3
14
Oxaliplatin Approved, Investigational Phase 1, Phase 2 61825-94-3 5310940 9887054 6857599, 9887054 43805
15
Fluorouracil Approved Phase 1, Phase 2 51-21-8 3385
16
Levoleucovorin Approved Phase 1, Phase 2 68538-85-2
17
Cisplatin Approved Phase 2 15663-27-1 84093 441203 2767
18
leucovorin Approved, Nutraceutical Phase 1, Phase 2 58-05-9 54575, 6560146 143
19
Folic Acid Approved, Nutraceutical, Vet_approved Phase 1, Phase 2 59-30-3 6037
20 Trace Elements Phase 1, Phase 2
21 Vitamin B Complex Phase 1, Phase 2
22 Vitamins Phase 1, Phase 2
23 Immunosuppressive Agents Phase 1, Phase 2
24 Protective Agents Phase 1, Phase 2
25 Antidotes Phase 1, Phase 2
26 Antimetabolites Phase 1, Phase 2
27 Antimetabolites, Antineoplastic Phase 1, Phase 2
28 Micronutrients Phase 1, Phase 2
29 Bone Density Conservation Agents Phase 1, Phase 2
30 Calcium, Dietary Phase 1, Phase 2
31 Folate Nutraceutical Phase 1, Phase 2
32 Vitamin B9 Nutraceutical Phase 1, Phase 2
33
Paclitaxel Approved, Vet_approved Phase 1 33069-62-4 36314
34 Tegafur Approved Phase 1 17902-23-7
35 Albumin-Bound Paclitaxel Phase 1
36 Immunoglobulins Phase 1
37 Antibodies Phase 1
38
s 1 (combination) Phase 1
39 Antimitotic Agents Phase 1
40 Antineoplastic Agents, Phytogenic Phase 1
41
Trastuzumab Approved, Investigational 180288-69-1 9903
42
nivolumab Approved 946414-94-4
43 Mitogens

Interventional clinical trials:

(show all 18)
id Name Status NCT ID Phase
1 Difference of Gastric Microbiota in the Process of Correa's Model. Recruiting NCT02833363 Phase 4
2 Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Completed NCT00538850 Phase 3
3 C-Met Inhibitor AMG 337, Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Treating Patients With Advanced Stomach or Esophageal Cancer Unknown status NCT02344810 Phase 1, Phase 2
4 A Study of Genomic-guided 'Standard-of-care' Chemotherapy for in Advanced Gastric Cancer Patients Recruiting NCT01100801 Phase 2
5 A Dose-escalation Study of ARX788, IV Administered in Subjects With Advanced Cancers With HER2 Expression Recruiting NCT02512237 Phase 1
6 Biweekly SOLAR, as First-line C/T in Pts With Gastric, Pancreatic and Biliary Cancers Not yet recruiting NCT03162510 Phase 1
7 Prognostic Value and Clinical Pathology of c-MET Expression and Amplification in Gastric Carcinoma Unknown status NCT02002416
8 Confocal Laser Endomicroscopy for the Diagnosis of Gastric Intestinal Metaplasia, Intraepithelial Neoplasia, and Carcinoma Unknown status NCT01642797
9 Clinical Relevance of ROS (V-ros UR2 Sarcoma Virus Oncogene Homolog) Aberrations in Solid Tumours Unknown status NCT01596374
10 Human Epidermal Growth Factor Receptor 2 (HER-2) Status in Gastric and Gastro-Esophageal Junction (GEJ) Carcinoma Completed NCT02731313
11 Trastuzumab Based Therapy in HER2 Positive AGC Completed NCT03024450
12 Esophageal Cytology With FISH in Detecting Esophageal Cancer Completed NCT02100189
13 Biomarker-Integrated Umbrella, Advanced Gastric Cancer Recruiting NCT02951091
14 Liquid Biopsy in Monitoring the Therapeutic Efficacy of Targeted Therapy in Advanced/Metastatic Gastric Cancer Recruiting NCT02610218
15 PCLE for the Diagnosis of Gastric Intestinal Metaplasia, Intraepithelial Neoplasia, and Carcinoma Recruiting NCT02515721
16 Family and Personal History of Malignancy in Intraductal Papillary Mucinous Neoplasm (IPMN) Recruiting NCT01104077
17 Malignant Progression of Anal Intra-epithelial Neoplasia in a Cohort of Patients Recruiting NCT01877135
18 Pilot Study of Oral 852A for Elimination of High-Grade Dysplasia in Barrett's Esophagus Terminated NCT00386594

Search NIH Clinical Center for Stomach Carcinoma in Situ

Genetic Tests for Stomach Carcinoma in Situ

Anatomical Context for Stomach Carcinoma in Situ

Publications for Stomach Carcinoma in Situ

Variations for Stomach Carcinoma in Situ

Expression for Stomach Carcinoma in Situ

Search GEO for disease gene expression data for Stomach Carcinoma in Situ.

Pathways for Stomach Carcinoma in Situ

GO Terms for Stomach Carcinoma in Situ

Sources for Stomach Carcinoma in Situ

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....